Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

Teleflex Reports Better Than Expected Q4 Earnings, Issues Mixed FY22 Guidance

Teleflex Incorporated (NYSE:TFX) reported Q4 FY21 revenues of $761.9 million, up 7.1% Y/Y, up 7.9% on a constant currency basis, beating the consensus of $748.63 million.

  • The revenue growth was attributable to higher sales from Anesthesia and Surgical segments.
  • Adjusted diluted EPS increased 10.8% to $3.60, above the consensus of $3.53.
  • The gross margin improved from 53.9% to 55.1%.
  • Guidance: Teleflex expects FY22 revenue growth of 2.3% to 3.8%, equivalent to $2.87 billion - $2.91 billion, versus the consensus of $2.92 billion. 
  • On a constant currency basis, the Company expects full-year 2022 revenue growth of 4.0% to 5.5%.
  • The Company estimates 2022 adjusted EPS of $13.70 to $14.30, +2.8% - 7.3% Y/Y, compared to the consensus of $14.04.
  • The divestiture of the respiratory assets is estimated to be dilutive to 2022 adjusted earnings per share by $0.17.
  • Price Action: TFX shares are trading at $322.34 during the market session on the last check Thursday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.